#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	24766	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2091	1162.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1384	1384	C	1387	C	1332	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46526	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3671	1250.9	0	.	n	.	0	T695C	SNP	695	695	T	1058	1058	C	1411	C,A	1359,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46526	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3671	1250.9	0	.	n	.	0	A1638G	SNP	1638	1638	A	2001	2001	G	1365	G,A,C	660,653,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46526	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3671	1250.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2334	2334	C	1422	C	1356	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46526	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3671	1250.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2408	2408	A	1428	A	1381	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	46526	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3671	1250.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2960	2960	C	1384	C	1342	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2914	folP	855	855	100.0	folP.l15.c4.ctg.1	1474	195.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1014	1016	AGC	305;305;306	A;G;C,T	296;293;293,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8168	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3281	245.8	1	SNP	p	S91F	1	.	.	271	273	TTC	552	554	TTC	286;285;286	T;T;C,T	273;272;271,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8168	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3281	245.8	1	SNP	p	G95N	0	.	.	283	285	GGC	564	566	GGC	284;282;283	G;G;C	269;266;267	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	8168	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3281	245.8	1	SNP	p	D95G	1	.	.	283	285	GGC	564	566	GGC	284;282;283	G;G;C	269;266;267	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2620	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1360	190.3	1	SNP	p	G45D	0	.	.	133	135	GGC	501	503	GGC	328;328;323	G;G;C	310;306;307	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1330	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1079	121.5	0	.	n	.	0	A197.	DEL	197	197	A	542	542	A	294	A	281	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8614	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3074	276.3	1	SNP	p	D86N	0	.	.	256	258	GAC	645	647	GAC	353;355;360	G;A;C	343;335;346	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8614	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3074	276.3	1	SNP	p	S87R	1	.	.	259	261	CGT	648	650	CGT	362;364;367	C,A,G;G,T;T,C	348,1,1;348,1;349,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8614	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3074	276.3	1	SNP	p	R87I	0	.	.	259	261	CGT	648	650	CGT	362;364;367	C,A,G;G,T;T,C	348,1,1;348,1;349,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8614	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3074	276.3	1	SNP	p	R87W	0	.	.	259	261	CGT	648	650	CGT	362;364;367	C,A,G;G,T;T,C	348,1,1;348,1;349,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	8614	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3074	276.3	1	SNP	p	S88P	0	.	.	262	264	TCC	651	653	TCC	361;367;370	T;C;C	346;354;357	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	6312	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2574	241.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1582	1584	GGC	282;278;278	G,T;G;C	270,1;266;259	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1343	1345	GCC	344;342;347	G;C,T;C	325;327,1;330	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1346	1348	ATG	349;347;349	A;T;G	330;330;328	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1358	1360	ACC	333;331;331	A,G;C;C	303,1;320;317	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1358	1360	ACC	333;331;331	A,G;C;C	303,1;320;317	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1859	1861	ACC	261;261;261	A;C;C	250;253;251	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1913	1915	GCG	221;216;216	G;C,G;G,C	205;176,2;194,1	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1913	1915	GCG	221;216;216	G;C,G;G,C	205;176,2;194,1	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2036	2038	GGT	240;240;239	G;G;T,C	222;224;221,1	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2045	2047	GGC	217;213;208	G,A;G;C	196,2;197;192	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	6036	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2528	234.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2063	2065	CCG	181;184;181	C,G;C,G;G	160,4;162,2;153	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	9566	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3122	302.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1613	1615	CCG	300;297;300	C;C;G	291;291;289	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4146	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1788	228.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	557	557	C	281	C,G	262,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4858	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1647	290.1	0	.	p	.	0	E38K	NONSYN	112	114	GAA	505	507	AAA	355;353;355	A,G;A;A	338,5;338;336	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4858	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1647	290.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	526	528	GTT	364;362;363	G,A;T;T	347,5;345;344	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4858	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1647	290.1	0	.	p	.	0	G48E	NONSYN	142	144	GGA	535	537	GAA	367;367;375	G;A,G;A	346;339,4;350	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4858	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1647	290.1	1	SNP	p	G120K	1	.	.	358	360	AAG	751	753	AAG	407;408;407	A,C,G;A,G;G,T,A	384,2,1;391,1;378,1,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4858	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1647	290.1	1	SNP	p	A121N	1	.	.	361	363	AAC	754	756	AAC	408;407;408	A,G;A,C;C	389,1;392,1;388	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	4858	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1647	290.1	1	SNP	p	N121D	0	.	.	361	363	AAC	754	756	AAC	408;407;408	A,G;A,C;C	389,1;392,1;388	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	17020	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4758	352.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1838	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	969	186.5	1	SNP	p	V57M	1	.	.	169	171	ATG	488	490	ATG	362;364;365	A;T;G	345;346;349	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
